Targeting the Transcriptional Addiction of Leukemia Stem Cells by a New Class of Protein Kinase Inhibitors
– ASH, December 2017, Oral Presentation

Protein Homeostatic Modulators, a Novel Class of Cereblon-Targeting Small Molecules as Potential Clinical Candidates in Multiple Myeloma
– ASH, December 2017, Poster Presentation

Novel Small Molecule Inhibitors Co-Targeting CK1a and P-Tefb Disrupt Super-Enhances and Eradicate Acute Myeloid Leukemia in a Mouse Model
– EHA, June 2017, Late Breaking Abstract